No profile data available.
iRhythm Technologies, Inc. (IRTC) is a healthcare company in the heart treatment equipment industry, based in San Francisco, United States, with about 2,400 full-time employees.
It reported revenue of $591.84 million for fiscal year 2024, up 20.1% from fiscal year 2023, and net income of -$113.29 million. In Q3 2025 (the quarter ended September 30, 2025) revenue was $192.88 million, up 30.7% from a year before. Its market capitalization was $3.52 billion as of October 9, 2026.
Figures from company filings and market data; latest fiscal year ended December 31, 2024; market data as of October 9, 2026.
, a digital healthcare company, engages in the design, development, and commercialization of device-based technology that provides ambulatory cardiac monitoring services to diagnose arrhythmias in the United States.
iRhythm Technologies reported $591.84 million in revenue for fiscal year 2024, up 20.1% from $492.68 million in fiscal year 2023. In Q3 2025 revenue was $192.88 million.
$3.52 billion as of October 9, 2026.
Listed companies of a similar size in the same industry (heart treatment equipment) include Heartflow, Inc. (HTFL), LivaNova PLC (LIVN), Pulse Biosciences, Inc. (PLSE), AtriCure, Inc. (ATRC).